Next Biomedical Co.,Ltd. (KOSDAQ:389650)
92,400
+1,800 (1.99%)
Last updated: Dec 9, 2025, 10:59 AM KST
Next Biomedical Revenue
Next Biomedical had revenue of 4.93B KRW in the quarter ending September 30, 2025, with 125.07% growth. This brings the company's revenue in the last twelve months to 14.90B, up 70.64% year-over-year. In the year 2024, Next Biomedical had annual revenue of 9.54B with 95.46% growth.
Revenue (ttm)
14.90B
Revenue Growth
+70.64%
P/S Ratio
49.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
739.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.54B | 4.66B | 95.46% |
| Dec 31, 2023 | 4.88B | 2.09B | 74.67% |
| Dec 31, 2022 | 2.80B | 527.74M | 23.28% |
| Dec 31, 2021 | 2.27B | 6.63M | 0.29% |
| Dec 31, 2020 | 2.26B | 1.46B | 182.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 113.20T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 23.11T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |